Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

Novus Biologicals | Catalog # NBP2-42213

Novus Biologicals
Loading...

Key Product Details

Species Reactivity

Validated:

Human, Mouse

Cited:

Human

Applications

Validated:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Flow Cytometry

Cited:

Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Lambda Clone # 6C8.2F9

Format

BSA Free
Loading...

Product Specifications

Immunogen

Partial recombinant human CD141 protein (between amino acids 200-400) [UniProt P07204].

Localization

Transmembrane protein with Extracellular, Helical and Cytoplasmic domains.

Marker

Endothelial Cells Damage Marker

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 Lambda

Theoretical MW

60.3 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

Western Blot: Thrombomodulin/BDCA-3 Antibody (6C8.2F9)BSA Free [NBP2-42213]

Western Blot: Thrombomodulin/BDCA-3 Antibody (6C8.2F9)BSA Free [NBP2-42213]

Western Blot: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) [NBP2-42213] - Western blot analysis of Thrombomodulin/BDCA-3 [6C8.2F9] in mouse heart lysate at 5 ug/ml.
Immunohistochemistry-Paraffin: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free [NBP2-42213]

Immunohistochemistry-Paraffin: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free [NBP2-42213]

Immunohistochemistry-Paraffin: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) [NBP2-42213] - IHC analysis of a formalin fixed paraffin embedded tissue section of human placenta using Thrombomodulin/BDCA-3 antibody (clone 6C8.2F9) at 15 ug/ml concentration. The antibody generated specific staining in the endothelial cells of placental blood vessels while all other cell types including RBCs were found negative for Thrombomodulin.
Flow Cytometry: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free [NBP2-42213]

Flow Cytometry: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free [NBP2-42213]

Flow Cytometry: Thrombomodulin/BDCA-3 Antibody (6C8.2F9) [NBP2-42213] - 1 million human PBMCs were immunostained with 1ug of Thrombomodulin/BDCA-3 antibody (clone 6C8.2F9) followed by detection via labelling with 0.5 ug of goat anti-mouse IgG-PE. Blue line represents cells alone, green line represents isotype control and shifted red line represents test purified antibody clone 6C8.2F9.

Applications for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

Application
Recommended Usage

Flow Cytometry

1 ug / million cells

Immunohistochemistry

10 - 15 ug/ml

Immunohistochemistry-Paraffin

10 - 15 ug/ml

Western Blot

4-5 ug/ml
Application Notes
Thrombomodulin is a 575 amino acids long protein with predicted molecular weight of 60.3 kDa, however, the post translationally modified /glycosylated protein may run at relatively higher molecular weight position on Western blot. Endothelial cells are unique in synthesizing thrombomodulin protein, but its presence in some other cell types such as dendritic cells/PBMCs has also been reported. The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Protein G purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: Thrombomodulin/BDCA-3

Thrombomodulin (THBD/CD141) is a transmembrane glycoprotein which acts as a physiological anticoagulant and its anticoagulation activities are accomplished by transforming thrombin from a pro-coagulant to an anticoagulant, directly inhibiting its clotting /cell activation potential. THBD generates a 1:1 stoichiometric complex with thrombin resulting in the activation of protein C which then scissions the activated coagulation cofactors (factor Va and factor VIIIa) and thereby reducing the amount of thrombin generated. THBD is expressed mainly by endothelial cells, however, its presence on the surface of other cell types such as epithelial cells, mesothelial cells, immune cells, osteoblasts and islet cells has also been documented. Besides its critical role in the regulation of coagulation process, THBD implicates in inflammation, fibrinolysis and cellular proliferation also. It provides protection against endothelial injury as well as microvascular thrombosis and it acts as a negative regulator of the complement system. Mutations in THBD gene have been linked to disorders such as Thrombophilia due to thrombomodulin defect (THPH12) and atypical haemolytic uraemic syndrome (aHUS)/ Hemolytic uremic syndrome atypical 6 (AHUS6).

Alternate Names

BDCA-3, BDCA3, CD141, Fetomodulin, THBD, THRM

Entrez Gene IDs

7056 (Human)

Gene Symbol

THBD

UniProt

Additional Thrombomodulin/BDCA-3 Products

Product Documents for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

Customer Reviews for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free

There are currently no reviews for this product. Be the first to review Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free and earn rewards!

Have you used Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Thrombomodulin/BDCA-3 Antibody (6C8.2F9) - BSA Free (NBP2-42213):

Thrombomodulin/BDCA-3 Antibody (6C8.2F9):
Reagents Required
Wash Buffer: 1X PBS (0.145 M NaCl, 0.0027 M KCl, 0.0081 M Na2HPO4, 0.0015 M KH2PO4, pH 7.4)
Incubation Buffer: 1% bovine serum albumin, 1% normal donkey serum, 0.3% Triton X-100, and 0.01% sodium azide in PBS
Primary Antibodies
Cell and Tissue Staining Kits: Kits include Biotinylated Secondary Antibodies, Serum Blocking Reagent, Peroxidase Blocking Reagent, Avidin Blocking Reagent, Biotin Blocking Reagent, High Sensitivity Streptavidin-HRP Conjugate (HSS-HRP), and Chromogen Solution. Kits are available with chromogenic substrates 3,3' Diaminobenzidine (DAB, brown precipitate) or 3-amino-9-ethylcarbazole (AEC, red precipitate).
DAB Enhancer (Catalog # CTS010)
Hematoxylin Counterstain
Aqueous Mounting Medium (Catalog # CTS011)
Antigen Retrieval Reagents (if required; Protocol for Heat-induced Epitope Retrieval (HEIR))
Materials
Gelatin-coated Slides (Protocol for Gelatin-coated Slides for Histological Tissue Sections)
Coverslips

Procedure
This staining protocol has been developed and optimized for use with R&D Systems Cell and Tissue Staining Kits.

1. Tissue must be rehydrated before commencing staining protocol.
a. Immerse the slides in xylene (mixed isomers) 2 times for 10 minutes each.
b. Immerse the slides in 100% alcohol 2 times for 10 minutes each.
c. Immerse the slides in 95% alcohol for 5 minutes.
d. Immerse the slides in 70% alcohol for 5 minutes.
e. Immerse the slides in 50% alcohol for 5 minutes.
f. Rinse the slides with deionized H2O.
g. Rehydrate the slides with wash buffer for 10 minutes. Drain the excess wash buffer.
Note: Excessive fixation may result in the masking of an epitope and strong non-specific background signal that can obscure specific labeling. If necessary, an antigen retrieval protocol can be performed at this time.

Note: Endogenous peroxidase and biotin can react with secondary reagents and cause non-specific background staining. R&D Systems Cell and Tissue Staining Kits contain reagents to address these potential artifacts (applied in protocol steps 3 - 7).

2. Surround the tissue with a hydrophobic barrier using a barrier pen.

3. To quench endogenous peroxidase activity, incubate the sample with 1-3 drops peroxidase blocking reagent (3% H2O2 in water or methanol) for 5-15 minutes.

4. Rinse the sample, then gently wash in wash buffer for 5 minutes.

5. To reduce non-specific hydrophobic interactions between the primary antibodies and the tissue, block the section with 1-3 drops of serum blocking reagent for 15 minutes. Drain the slides and wipe away any excess blocking reagent before proceeding to the next step. Do not rinse.

6. To block binding to endogenous biotin, incubate the sample with 1-3 drops of avidin blocking reagent for 15 minutes. Rinse the sample with wash buffer, drain slides, and wipe away any excess wash buffer.

7. To block subsequent binding to the avidin applied in step 6, incubate the sample with 1-3 drops of biotin blocking reagent for 15 minutes. Rinse with wash buffer, drain the slides, and wipe away any excess wash buffer.

8. Incubate the sample with primary antibodies in Incubation Buffer. Follow manufacturer's recommendations regarding working dilution for the primary antibody. For chromogenic IHC staining of paraffin-embedded tissue sections using R&D Systems antibodies, it is recommended to incubate overnight at 2-8 degrees C. This incubation regime allows for optimal specific binding of antibodies to tissue targets and reduces non-specific background staining. These variables may need to be optimized for your system.

Note: Appropriate controls are critical for the accurate interpretation of IHC/ICC results. All IHC/ICC experiments should include a negative control using the incubation buffer with no primary antibody to identify non-specific staining of the secondary reagents. Additional controls can be employed to support the specificity of staining generated by the primary antibody. These include absorption controls, isotype matched controls (for monoclonal primary antibodies), and tissue type controls.

9. Rinse the sample with wash buffer. Wash 3 times with wash buffer for 5 minutes each, and drain the slides.

10. Incubate the sample with 1-3 drops of biotinylated secondary antibodies for 30-60 minutes, adjusting the incubation time depending on the thickness of the section (approximately 30 minutes for 5-10 um thick sections and 60 minutes for 10-20 um thick sections).

11. Rinse with wash buffer 3 times for 15 minutes each and drain the slides.

12. Incubate the sample with 1-3 drops of High Sensitivity Streptavidin-HRP conjugate (HSS-HRP) for 30 minutes. This signal amplification technique is referred to as the labeled streptavidin-biotin (LSAB) method.

Note: High Sensitivity Streptavidin is a chemical analog of Streptavidin that has little net positive charge at neutral or slightly alkaline pH and will interact only with biotin attached to secondary antibodies. HSS-HRP shows little or no non-specific binding to phospholipids, nucleic acids, and carbohydrate binding proteins.

13. Rinse and wash 3 times in wash buffer for 2 minutes each.

14. Calculate the required working volume of DAB/AEC Chromogen Solution given that 100-200 uL is required to cover the entire tissue section on a single slide. Add 1-5 drops of DAB/AEC Chromogen Solution to cover the entire tissue section and incubate for 3-20 minutes. Monitor the intensity of the tissue staining under a light microscope. Colored precipitate will localize to the sites of antigen expression as the chromogenic substrate is converted by HRP enzyme into insoluble end product.

Note: DAB and AEC are hazardous materials. Gloves and safety glasses should be worn and all steps performed inside a fume hood. Please refer to the MSDS for safe deactivation.

Note: If required, DAB Enhancer (Catalog # CTS010) can be used to intensify the DAB Chromogen solution.

15. Rinse the sample with wash buffer 3 times for 10 minutes each.

16. Rinse in deionized H2O and drain the slides.

17. Stained tissue can be mounted either without nuclear counterstaining or counterstained with nuclear counterstain hematoxylin for better visualization of the tissue morphology.

Note: Hematoxylin counterstain can obscure visualization of targets localized in cell nuclei.

18. Cover stained tissue with a coverslip of an appropriate size, place slides vertically on filter paper or a towel to drain excess mounting medium, and allow them to dry.

Note: Unlike DAB, AEC is soluble in alcohols and xylene. Tissue sections subjected to an HRP-AEC protocol should be coverslipped using only aqueous mounting media.

19. Visualize staining of tissue under a microscope using a bright-field illumination.

Note: Initial IHC/ICC studies often require further optimization and/or additional troubleshooting steps.

Triton is a registered trademark of Dow Chemical.

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies